iifl-logo

LIC MF Healthcare Fund Regular G

LIC MF Healthcare Fund Regular G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Regular G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Karan Doshi

Net Assets (Rs. cr)

87.7

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

LIC MF Healthcare Fund Regular G - Nav Details

Nav Date

:  07-Aug-2025

NAV [Rs.]

:  29.0243

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Regular G- NAV Chart

LIC MF Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-4.55
-0.86
4.61
-0.74
7.72
18.67
14.38
17.96
Category Avg
-4.65
-2.22
4.21
0.78
7.57
23.3
19.33
16.15
Category Best
-2.64
-0.09
6.99
3.79
21.4
28.3
22.5
34.92
Category Worst
-6.09
-7.24
1.49
-3.18
-7.86
18.71
14.39
-4.39

LIC MF Healthcare Fund Regular G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
Gland Pharma13,351
Anthem Bioscienc12,536

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.10538519.19
EquityApollo HospitalsHealthcare Services5.5467235.04
EquityTorrent Pharma.Pharmaceuticals & Biotechnology5.40131304.91
EquityCiplaPharmaceuticals & Biotechnology5.33312184.85
EquityDivi's Lab.Pharmaceuticals & Biotechnology4.4661584.06
EquityFortis Health.Healthcare Services3.97421023.61
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.92313013.56
EquityPiramal PharmaPharmaceuticals & Biotechnology3.731721113.39
EquityAbbott IndiaPharmaceuticals & Biotechnology3.669683.33
EquityNeuland Labs.Pharmaceuticals & Biotechnology3.5224143.20
EquityAlkem LabPharmaceuticals & Biotechnology3.4462123.12
EquityGland PharmaPharmaceuticals & Biotechnology3.03133512.75
EquityIpca Labs.Pharmaceuticals & Biotechnology2.97183112.69
EquityArtemis MedicareHealthcare Services2.861088322.60
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.81119942.55
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.6647962.42
EquityMetropolis HealtHealthcare Services2.50114172.27
EquityDr Agarwal's HeaHealthcare Services2.49496842.26
EquityMankind PharmaPharmaceuticals & Biotechnology2.4285772.20
EquityConcord BiotechPharmaceuticals & Biotechnology2.40123412.18
EquityMax HealthcareHealthcare Services2.30167752.09
EquitySyngene Intl.Healthcare Services2.22282602.01
EquityGlobal HealthHealthcare Services2.15149521.96
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.8997361.72
EquityVinati OrganicsChemicals & Petrochemicals1.7687411.59
EquityOneSource Speci.Pharmaceuticals & Biotechnology1.5973321.44
EquityCohance LifePharmaceuticals & Biotechnology1.48135051.34
EquityAcutaas ChemicalPharmaceuticals & Biotechnology1.4297111.28
EquityZydus Lifesci.Pharmaceuticals & Biotechnology1.38129571.25
EquityLinde IndiaChemicals & Petrochemicals1.1315591.02
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.05125360.95
Cash & Cash Equivalent
Reverse RepoTREPS-/-4.4704.06
Net CA & OthersNet CA & Others-/--0.060-0.05

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
38,853.80
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.